|Description||A 5-HT1A receptor partial agonist that is less active compared to R-(+)-8-hydroxy-DPAT.|
|Brife Description||5-HT1A partial agonist|
|Synonyms||S-(-)-8-OH-DPAT HBr; Hydroxy-DPAT hydrobromide, (S)-(-)-8-; (7S)-7-(dipropylamino)-5,6,7,8-tetrahydronaphthalen-1-ol hydrobromide|
EMD 281014 hydrochloride
EMD 281014 hydrochloride is a selective 5-HT2A antagonist with preference for human 5-HT2A over 5-HT2C receptors (Ki = 0.87 and 557 nM, respectively). EMD 28101...
α-Methyl-5-hydroxytryptamine maleate, a salt of α-Methylserotonin maleate, is a 5-HT2B receptor selective agonist with pKi values of 8.4, 6.1 and 7.3 at 5-HT2B,...
BMY 14802 hydrochloride
BMY 14802 hydrochloride is a potent sigma receptor antagonist (IC50 = 112 nM) with weak affinity for 5-HT1A and α1 receptors. BMY 14802 is potentially used as a...
The hydrochloride salt form of Donitriptan, which is a novel 5-HT derivative with potent, selective, and unique high intrinsic activity at 5-HT1B/1D receptors a...
TCB-2 is a high affinity 5-HT2A receptor agonist (Ki = 0.73 and 0.75 nM for rat and human receptors, respectively). TCB-2 stimulates IP3 accumulation in NIH3T3 ...
Way 100135 is a selective 5-HT1A receptor antagonist originated by Wyeth with IC50 value of 15 nM. IC 50 values for 5-HT1B, 1C, 2,α1, α2 and D2 receptors are ov...
BRL 15572 hydrochloride
BRL 15572 hydrochloride is a selective h5-HT1D antagonist with 60-fold selectivity over h5-HT1B.
Nefazodone is a selective serotonin 5-HT2 receptor antagonist. It is an antidepressant under the development of Bristol-Myers Squibb. Its sale was discontinued ...